Financhill
Sell
6

MRNA Quote, Financials, Valuation and Earnings

Last price:
$30.53
Seasonality move :
28.18%
Day range:
$30.70 - $32.42
52-week range:
$30.70 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.37x
P/B ratio:
1.00x
Volume:
10M
Avg. volume:
11.8M
1-year change:
-64.62%
Market cap:
$11.9B
Revenue:
$6.8B
EPS (TTM):
-$5.82

Earnings Data

Next earnings date for MRNA
Feb 14
2025
Most recent earnings per share
$0.03
Beat by $1.97
(Nov 7/2024)
Consensus Estimate
-$1.94
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $190.4M -- -- -$2.88 --
02/14/2025 Q4 $941.1M -- -- -$2.73 --
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $221M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.07 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- -- -$9.53 -$2.05 -$7.48
06/30/2023 Q2 -- -- -$3.62 -$4.12 $0.50
03/31/2023 Q1 -- -- $0.19 -$1.73 $1.92
12/31/2022 Q4 -- -- $3.61 $4.60 -$0.99
09/30/2022 Q3 -- -- $2.53 $3.11 -$0.58
06/30/2022 Q2 -- -- $5.24 $4.49 $0.75
03/31/2022 Q1 -- -- $8.58 -- --
12/31/2021 Q4 -- -- $11.29 -- --
09/30/2021 Q3 -- -- $7.70 -- --
06/30/2021 Q2 -- -- $6.46 -- --
03/31/2021 Q1 -- -- $2.84 -- --
12/31/2020 Q4 -- -- -$0.69 -- --
09/30/2020 Q3 -- -- -$0.59 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.35 -- --
12/31/2019 Q4 -- -- -$0.37 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.41 -- --
03/31/2019 Q1 -- -- -$0.40 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.27 -- --
06/30/2018 Q2 -- -- -$0.24 -- --
03/31/2018 Q1 -- -- -$0.19 -- --
12/31/2017 Q4 -- -- -$0.10 -- --

Moderna Earnings Questions

  • How Much did Moderna Generate in Revenue Last Quarter?

    Moderna reported $1.9B worth of top line sales in its most recent quarter.

  • Did Moderna Beat Earnings Last Quarter?

    Moderna announced earnings per share of $0.03 which represents a beat of analyst forecast a -$1.94 per share.

  • Is Moderna Profitable?

    Moderna reported $1.3B that represents $3.36 per share over the last quarter.

  • What is the Analyst Consensus for Moderna EPS Next Year?

    Moderna's earnings are forecast to decrease from -$12.33 per share to -$9.03 per share next year representing a decrease of -24.76%.

  • When is Moderna's Earnings Date?

    Moderna's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Will Palantir Stock Be Worth in 2030?
What Will Palantir Stock Be Worth in 2030?

Palantir Technologies (NYSE: PLTR) has emerged from a growth slowdown…

Is Rollins Stock a Buy, Sell or Hold?
Is Rollins Stock a Buy, Sell or Hold?

Pest control giant Rollins (NYSE:ROL) is the parent company of…

Why Did Bill Ackman Buy Uber?
Why Did Bill Ackman Buy Uber?

In early 2025, billionaire investor Bill Ackman, CEO of Pershing…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 111x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
65
ATEX alert for Feb 12

Anterix [ATEX] is down 0.72% over the past day.

Buy
87
GDS alert for Feb 12

GDS Holdings [GDS] is up 0.32% over the past day.

Sell
30
SPSC alert for Feb 12

SPS Commerce [SPSC] is up 0.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock